- Key information
- Let’s stay in touch
- Employer’s area
- Locations
- Send CV
Moderna Poland Sp. z.o.o.
- Research & development
- Pharmaceutical industry/Biotechnology
- contract of employment
- substitution agreement
- Our mission is to deliver the greatest possible impact to people through mRNA medicines.
See what working for our company is like
Select department
What is the work in our company like?
Day in the Company
Benefits
- sharing the costs of sports activities
- private medical care
- sharing the costs of professional training & courses
- life insurance
- remote work opportunities
- flexible working time
- integration events
- corporate gym
- corporate sports team
- corporate library
- no dress code
- coffee / tea
- sharing the commuting costs
- employee referral program
- charity initiatives
- extra leave
- 1 month paid sabbatical after 5 years
- Office with WELL certification
- Computer glasses and contact lens reimbursement
- fruits
- retirement pension plan
- corporate credit card
- drinks
- leisure zone
- meal passes
- pre-paid cards
- sharing the costs of tickets to the movies, theater
Let’s stay in touch
Haven’t found any interesting job offer? No problem! Send us your resume and we will add it to our base. We browse our CV database during every recruitment project.
Send CV
Receive notifications about new recruitment projects and internship programs launched by this Employer. Stay informed!
Working for this Employer? Recommend the Employer to show other candidates that job offers placed by this Employer are worth considering.
Employer’s area
What makes us stand out among our competitors?
3 900
Over 3900 team members
12
Over 12 years of progress
48
products in pipeline
About us
In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.
- First stage: Candidate’s application.
Who? Candidate.
How? Moderna careers site.
All job offers are available on our careers site. Please don’t hesitate and apply now! - Next stage: Screening
Who? Talent Acquisition
How? Virtually – Webex.
What? Cultural fit & functional background. - Next stage: Interviews
Who? Hiring Manager + Business Stakeholders.
How? Virtually/on-site.
What? Cultural fit, potential, leadership and functional competences.
After the successful interview with hiring manager, Moderna Candidate Experience team invite candidates for the panel interview – it’s standard element of the recruitment process at Moderna. During the panel interview, candidate will have opportunity to meet with business stakeholders (around 3 or 4 interviews), with whom he/she will collaborate in this role very closely. It’s a great chance from candidates’ perspective to meet the team, before making final decision. - Last stage: Offer & feedback
How: Phone/virtually.
What? Offer, feedback.
After the last interview at Moderna, our recruiter will contact you shortly to inform you about the result of the recruitment process and feedback about your candidacy. In situation of a positive feedback, decision and acceptance of the proposed conditions, you will get more details about the next steps in hiring process.
At Moderna we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
We have a clear mission to propel the field of mRNA science forward and deliver new medicines to patients and a unique vision for how to achieve this mission.
Our Mission: To deliver on the promise of transformative messenger RNA (mRNA) science to bring new medicines to patients.
Our Vision: To unlock the potential of mRNA by establishing an ecosystem of teams and partners that will work together to develop the broadest possible array of drugs, across diverse therapeutic areas and routes of administration, for serious diseases that are not treatable today.
- 2010
Moderna incorporates - Moderna’s name combines the words "modified" and "RNA", which happens to contain the word "modern.” - 2011
Operations started - Moderna begins research into the production of mRNA medicines. Stéphane Bancel joins as founding CEO. - 2014
Expansion - New headquarters and labs open in Cambridge, Massachusetts. - 2015
First human dose of flu vaccine - Moderna initiates first-in-human dose of an mRNA vaccine (mRNA-1440), an H10N8 flu vaccine candidate. - 2016
New lease signed - Lease signed to build 200,000 sq ft GMP mRNA clinical manufacturing facility in Norwood, MA. - 2017
First human dose of multivalent vaccine - Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease – human metapneumovirus (hMPV virus) and parainfluenza virus.
- 2018
New facility opens - Moderna opens its state-of-the-art clinical development site in Norwood, MA. - 2019
First antibody encoded by mRNA - Moderna announces dosing of the first antibody encoded by mRNA in a clinical trial. - 2020
CDC recommendation - The U.S. Centers for Disease Control and Prevention votes to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older in the U.S. - 2022
Moderna receives full approval for COVID-19 vaccine by U.S. FDA - The U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older in the U.S.
Moderna people hold a deep sense of responsibility for each other, patients, the environment and our local communities. Our people live our Values every day.
Our office in Poland
MESH - The brand new Moderna Enterprise Solutions Hub is an exciting next step in our global expansion. Based in the heart of Warsaw, it provides our growing organization with innovative and strategic support to help scale our business for the benefit of people and patients around the world.
We offer opportunities in Digital, Finance, Human Resources, Cilinical Trial Safty Operations, Legal & Compliance and Supply Chain.
